Breaking News
Get 55% Off 0
Get Premium Data for Cyber Monday: Up to 55% Off InvestingPro
CLAIM SALE
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Moderna's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
44.44 +1.50    +3.49%
06/12 - Closed. Currency in USD
After Hours
44.38
-0.09
-0.20%
0:58:24 - Real-time Data
  • Volume: 8,742,718
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 43.16 - 46.62
Type:  Equity
Market:  United States
Moderna 44.44 +1.50 +3.49%

Moderna Company Profile

 
Read the Moderna company profile to learn more about the business and the management team. View Moderna Inc facts about how many employees Moderna has, MRNA company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

5600

Equity Type

ORD

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address 200 Technology Square
Cambridge, 02139
United States
Phone 617 714 6500
Fax 617 649 3910

Top Executives

Name Age Since Title
Noubar B. Afeyan 60 2010 Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board
Stephane Bancel 50 2011 CEO & Director
Melissa J. Moore - 2016 Member of Scientific Advisory Board
Jack W. Szostak - 2014 Chairman of Scientific Advisory Board
Richard C. Willson - 2014 Member of Technology Advisory Board
Fred E. Regnier - 2014 Member of Technology Advisory Board
John G. Aunins 63 2014 Member of Technology Advisory Board
James R. Swartz - 2014 Member of Technology Advisory Board
Elizabeth G. Nabel 72 2021 Independent Director
Elizabeth Edith Tallett 74 2020 Independent Director
Ulrich H. von Andrian-Werburg - - Member of Scientific Advisory Board
Francois Nader 67 2019 Independent Non Executive Director
Robert S. Langer 75 2010 Member of Scientific Advisory Board
Paula T. Hammond 60 - Member of Scientific Advisory Board
Ron Eydelloth - - Member of Scientific Advisory Board
Paul L. Sagan 65 2018 Independent Non Executive Director
Ralph Weissleder - - Member of Scientific Advisory Board
Sandra J. Horning 75 2020 Independent Director
Rachel Green - - Member of Scientific Advisory Board
Michael Diamond - - Member of Scientific Advisory Board
David Mark Rubenstein 75 2024 Director
Shah Abbas Hussain 59 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Moderna (MRNA) Price Discussion

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rehan Khan
Rehan Khan Nov 15, 2024 18:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At 37. Moderna is very cheap
Roy Bhika
Roy Bhika Nov 08, 2024 19:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats going on with this stock
John Williams
John Williams Oct 02, 2024 22:16
Saved. See Saved Items.
This comment has already been saved in your Saved Items
As I predicted last November - $60s. Well done me.
johny sheikh
johny sheikh May 02, 2024 12:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next 135?
John Williams
John Williams Nov 02, 2023 11:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$69.50…
Ken Laing
Ken Laing Oct 26, 2023 5:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
At some point this will be a buy
John Williams
John Williams Oct 17, 2023 17:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hype stock. Trading pharma stocks is tedious at best, in this case, unrewarding too. I wouldn’t bother unless I heard news of a serious covid strain - the kind that sends crude oil down at least 10-15%.
Ferdinand Peelen
Ferdinand Peelen Aug 17, 2023 15:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What's up with Moderna today?
John Williams
John Williams Aug 07, 2023 16:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Told ya.
John Williams
John Williams Mar 30, 2023 21:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sc mortgage should dump this
Al Al
Al Al Mar 30, 2023 21:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They have high conviction in this, they believe it offers the best growth story and new drugs in the works.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email